Mirum Pharmaceuticals Announces Enrollment Completion in Phase 2b EMBARK Biliary Atresia Study
FOSTER CITY, Calif.--(BUSINESS WIRE)-- #alagillesyndrome--Mirum Pharmaceuticals Announces Enrollment Completion in Phase 2b EMBARK Biliary Atresia Study
News Ticker
- [ May 29, 2023 ] Sales Representative – Biotech – Selleck Chemicals LLC – San Francisco, CA San Francisco Biotech Jobs
- [ May 29, 2023 ] Sales Associate – Biotech – Selleck Chemicals LLC – Stanford, CA San Francisco Biotech Jobs
- [ May 28, 2023 ] Senior Manager, Quality Control Clinical Programs and LIMS Administration – Aimmune Therapeutics – Brisbane, CA San Francisco Biotech Jobs
- [ May 28, 2023 ] Senior Process Engineer – (Biotech Industry) – Hybrid – Harris Group – Lafayette, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Senior Director, Head of Medical Affairs – Cargo Therapeutics – San Mateo, CA San Francisco Biotech Jobs
Copyright © 2023 Biotech Networks, LLC
